Robert Langer's Net Worth

$1.16 Billion

Estimate Recalculated Mar 1, 2024 05:35PM EST

Who is Robert Langer?

Robert Langer has an estimated net worth of $1.16 Billion. This is based on reported shares across multiple companies, which include Moderna, Inc., WYETH, Fibrocell Science, Inc., DNIB UNWIND, INC., Seer, Inc., SQZ Biotechnologies Co, SELECTA BIOSCIENCES INC, Rubius Therapeutics, Inc., Lyra Therapeutics, Inc., Kala Pharmaceuticals, Inc., INVIVO THERAPEUTICS HOLDINGS CORP., Frequency Therapeutics, Inc., MOMENTA PHARMACEUTICALS INC, Ocata Therapeutics, Inc., MILLIPORE CORP /MA, Abpro Corp, ALSERES PHARMACEUTICALS INC /DE, and Echo Therapeutics, Inc..

SEC CIK

Robert Langer's CIK is 0001239757

Past Insider Trading and Trends

2007 was Robert Langer's most active year for acquiring shares with 12 total transactions. Robert Langer's most active month to acquire stocks was the month of May. 2013 was Robert Langer's most active year for disposing of shares, totalling 33 transactions. Robert Langer's most active month to dispose stocks was the month of April. 2005 saw Robert Langer paying a total of $257,440.00 for 104,200 shares, this is the most they've acquired in one year. In 2016 Robert Langer cashed out on 112,250 shares for a total of $433,500.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Moderna, Inc. (MRNA) Snapshot price: $99.2

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
0
0
May 3
Form 4
+0.01%
703
11.47M
Apr 28
Form 4
0
0
Apr 28
Form 4
0
0
Apr 29
Form 4
0
0
Jun 27
Form 4
+0.04%
4.56K
11.47M
Dec 11
Form 3
0
0
No matching records found

WYETH No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-12.56K
$49.58
-$424,326.29
0
Oct 15
Form 4
+50.77%
2.86K
8.51K
Jul 20
Form 4
+119.48%
2.96K
5.44K
Apr 24
Form 4
+25.00%
800
4K
Jan 2
Form 4
+97.91%
1.2K
2.43K
Apr 26
Form 4
+33.33%
800
3.2K
Jan 2
Form 4
1.2K
1.2K
Apr 27
Form 4
+50.00%
800
2.4K
Jan 2
Form 4
0
0
Apr 21
Form 4
+100.00%
800
1.6K
Jan 3
Form 4
0
0
Apr 22
Form 4
800
800
Jan 2
Form 3
0
0
No matching records found

Fibrocell Science, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
0
0
Jan 14
Form 4
0
0
Sep 25
Form 3
0
0
No matching records found

DNIB UNWIND, INC. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+2.07%
15K
$0.44
$6,600.00
738.42K
Aug 26
Form 4
0
0
Jun 21
Form 4
0
0
Jun 9
Form 4
0
0
May 28
Form 3
0
0
No matching records found

Seer, Inc. (SEER) Snapshot price: $1.77

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+3.34%
23.44K
725.85K
Jun 14
Form 4
+1.44%
9.95K
702.4K
Jun 15
Form 4
+89.53%
327.1K
692.46K
Jan 10
Form 4
0
0
Jun 17
Form 4
0
0
Dec 3
Form 4
+129.03%
205.83K
365.36K
Dec 8
Form 3
0
0
No matching records found